Background. The gut‐cardiac axis theory provides new insights into the complex
mechanisms of cardiac hypertrophy and provides new therapeutic targets. Cardiac …

Abstract Background Coronary Artery Disease (CAD) is primarily caused by inflammation
which is closely linked to the gut microbiota. Si-Miao-Yong-An (SMYA) decoction is a …

Abstract Context Shenxiang Suhe pill (SXSH), a traditional Chinese medicine, is clinically
effective against coronary heart disease, but the mechanism of cardiac-protective function is …

The objective of this study was to investigate the protective effects of Shengmai Yin (SMY)
on rats with chronic heart failure (CHF). Sprague‐Dawley rats were used to establish a CHF …

Ethnopharmacological relevance Heart failure (HF) after myocardial infarction (MI) is one of
the most common disabling and painful diseases. A traditional Chinese medicine (TCM) …

Background. The composition and metabolic activities of gut microbiota are strongly
interconnected with cardiac fibrosis (CF) and heart failure (HF). Qige Huxin formula (QHF), a …

In this study, we mainly investigated the effects of Shengmai San (SMS) on diabetic
cardiomyopathy (DCM) in db/db mice. The db/db mice were randomly divided into model …

Sheng Mai Yin (SMY) has therapeutic effects on myocardial infarction (MI), heart failure (HF),
diabetic cardiomyopathy (DCM), and myocarditis. To study whether SMY can relieve …

Abstract Ethnopharmacological relevance Qing Gan Zi Shen Decoction (QGZS) is a
traditional Chinese formula. It has been extensively used for decades in the treatment of …

Objective: To explore the mechanism of Shengmai Yin (SMY) for coronary heart disease
(CHD) by systemic pharmacology and chemoinformatics. Methods: Traditional Chinese …